PD-1 and PD-L1 expression on the prognosis of ovarian cancer.

Li, R P; Li, Y W; Guo, Y Z

Li, R P; Li, Y W; Guo, Y Z.

Afiliação

Li RP; Department of Gynaecology, Lanzhou University Second Hospital, Lanzhou City, China.
Li YW; Department of Gynaecology, Lanzhou University Second Hospital, Lanzhou City, China.
Guo YZ; Department of Gynaecology, Lanzhou University Second Hospital, Lanzhou City, China.

J Biol Regul Homeost Agents ; 33(4): 1161-1166, 2019.

Article em En | MEDLINE | ID: mdl-31309818

Assuntos

Antígeno B7-H1/metabolismo; Neoplasias Ovarianas/metabolismo; Receptor de Morte Celular Programada 1/metabolismo; Feminino; Humanos; Neoplasias Ovarianas/diagnóstico; Prognóstico

Palavras-chave

PD-1; PD-L1; ovarian cancer; prognosis

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links